Cost‐analysis of opportunistic influenza vaccination in general medical inpatients

Abstract

Influenza vaccination is an important preventative health measure in the elderly and those with medical comorbidities. It has been shown to reduce hospitalisations, cardiovascular and respiratory complications. A significant proportion of patients admitted to general medicine are eligible for opportunistic inpatient influenza vaccination. This study explores the cost‐effectiveness of such a strategy in reducing subsequent healthcare utilisation costs.